Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots

Pediatric Infectious Disease Journal

Volumn 19, Issue 1, 2000, Pages 30-36

  Paul, Malgorzata ^a,c   Petersen, Eskild ^d   Pawlowski, Zbigniew S ^c   Szczapa, Jerzy ^b  

^a Inst Microbiol Infect Dis U   (Poland)

^b Dept of Neonatal Infect Diseases   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

Congenital toxoplasmosis; Filter paper samples; IgM enzyme linked immunosorbent assay; Neonatal screening; Serologic diagnosis

Indexed keywords

FOLINIC ACID; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN;

ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONGENITAL TOXOPLASMOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NEWBORN; NEWBORN SCREENING; POLAND; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; TOXOPLASMA GONDII;

EID: 0033955520     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200001000-00007     Document Type: Article

References (23)

1. Aspöck H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis 1992;Suppl 84:32-7.
2. Garin JP. Toxoplasmose: aspects nouveaux dans la surveillance de la femme enceinte et nouveau-né. Feuill Biol 1988; 29:21-30.
3. Berger R, Merkel S, Rudin C. Toxoplasmosis and pregnancy: findings from umbilical cord blood screening in 30 000 newborn infants [German]. Schweiz Med Wochenschr 1995;125: 1168-73.
4. Eaton RB, Petersen E, Seppänen H, et al. Multicenter evaluation of a fluorometric enzyme immunocapture assay to detect Toxoplasma-specific immunoglobulin M in dried blood filter paper specimens from newborns. J Clin Microbiol 1996; 34:3147-50.
5. Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 1994;330:1859-63.
6. Lebech M, Andersen O, Christensen NC, et al. Feasibility of neonatal screening for Toxoplasma infection in the absence of prenatal treatment. Lancet 1999;353:1834-7.
7. Lebech M, Petersen E. Detection by enzyme immunosorbent assay of Toxoplasma gondii IgG antibodies in dried blood spots on PKU-filter paper from newborns. Scand J Infect Dis 1995;27:259-63.
8. Pawlowski ZS, Mrozewicz B, Kacprzak E, et al. Congenital toxoplasmosis in the Poznań region [Polish]. Gin Pol 1994;65: 409-12.
9. Pawlowski ZS. Clinical epidemiology of congenital toxoplasmosis in the Poznań region [Polish]. Klin Perin Gin 1995; Suppl XI:5-11.
10. Couvreur J. Toxoplasmose congénitale: prise en charge et devenir. Méd Mal Infect 1993;23(Spécial):176-82.
11. Hohlfeld J, Daffos F, Thulliez P, et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 1989;115:765-9.
12. Patel DV, Holfels EM, Vogel NP, et al. Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology 1996;199:433-40.
13. McAuley J, Boyer KM, Patel D, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin Infect Dis 1994;18: 38-72.
14. Roizen N, Swisher CN, Stein MA, et al. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1995;95:11-20.
15. Lebech M, Joynson DHM, Seitz HM, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis 1996;15: 799-805.
16. Bessières MH, Roques C, Berrebi A, et al. IgA antibody response during acquired and congenital toxoplasmosis. J Clin Pathol 1992;45:605-8.
17. Decoster A, Darcy F, Caron A, et al. Anti-P30 IgA antibodies as prenatal markers of congenital Toxoplasma infection. Clin Exp Immunol 1992;87:310-15.
18. Fricker-Hidalgo H, Pelloux H, Bost M, et al. Congenital toxoplasmosis: contribution of postnatal biological follow-up [French]. Presse Méd 1996;25:1868-72.
19. Duffy KT, Wharton PJ, Johnson JD, et al. Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting Toxoplasma specific IgM. J Clin Pathol 1989;42:1291-5.
20. Thulliez P, Dutriat P, Saulnier M, et al. Évaluation de trois réactifs de détection par immunocapture des IgM spécifiques de la toxoplasmose. Rev Fr Lab 1988;169:25-31.
21. Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and the newborn infant. 4th ed. Philadelphia: Saunders, 1995:140-267.
22. Cabalska MB, Nowaczewska J, Sendecka E, et al. Longitudinal study on early diagnosis and treatment of phenylketonuria in Poland. Eur J Pediatr 1996;155(Suppl 1):S53-5.
23. Erenz B, Jerzykowska M, Wieja E, et al. Results of neonatal screening for congenital hypothyroidism in Wielkopolska region [Polish]. In: Szczapa J, Twarowska I, eds. Postȩpy w Neonatologii: problemy endokrynologiczne okresu noworodkowego. Poznań, Poland: Wielkopolska Fundacja Neonatologii 1998:68-72.